Philip E. Silkoff, M.D. (Scientific Advisory Board Member)
Dr. Silkoff received his medical degree from the University of London and is an adult pulmonologist and an expert in allergic airways disorders such as asthma. Dr. Silkoff was Associate Professor at the University of Colorado until 2004 and has extensive publications in the fields of asthma and COPD focused on biomarkers e.g. exhaled nitric oxide. In 2008, Dr. Silkoff joined the pharmaceutical industry and has held positions at AstraZeneca and Janssen. Currently, Dr. Silkoff is Chief Medical Officer of Third Pole Therapeutics focusing on inhaled nitric oxide in pulmonary hypertension.
Dr. Silkoff has assisted Tolerys in its programs for several years and wishes to help Tolerys realize its objectives of providing a safe and effective immunomodulatory therapy for allergic disorders.
Gilles Marchal, M.D., Honorary Professor of the Institut Pasteur (Scientific Advisory Board Member)
Dr. Gilles Marchal is an M.D. who specialized in Immunology and the pathophysiology of mycobacterial infections. He developed his scientific career at the Institut Pasteur where he reached the rank of Professor and headed the Department of Pathophysiology as well as the National Reference Centre for Mycobacteria and Tuberculosis.
His scientific work has resulted in 93 papers published in top international journals, 37 reviews papers and in 2 granted patents. He was an active member of the Institut Pasteur Scientific Council as well as a member of the French Society for Immunology, the American Society of Microbiology, the American Association of Immunologists and the International Society of Experimental Hematology.
Hervé Bercovier, D.V.M., Professor Emeritus in Microbiology and Molecular Genetics of the Hebrew University of Jerusalem (Scientific Advisory Board Member)
Hervé Bercovier graduated as a D.V.M. from the Veterinary School of Maisons-Alfort and was a Lauréat of the Faculty of Medicine of Paris-Créteil. He is a former researcher at the Institut Pasteur and Vice President for Research and Development of Hebrew University, with forty years' experience as a researcher in medical microbiology, taxonomy, public health infectious diseases, molecular epidemiology of old and emerging diseases as well as vaccine and drug development. He published more than 150 scientific papers and reviews.
As a consultant to several startup companies, he helped them improve the development of biological products so they can reach their target market faster.
Irène Garcia, PhD, Associate Professor at the University of Geneva
Prof. Irène Garcia received her PhD degree from the University of Geneva where she is an Associate Professor at the Department of Pathology and Immunology of the Faculty of Medicine. She developed her scientific carrier in Switzerland and France working on the mechanisms controlling inflammation and host resistance against tuberculosis infection. She is an expert in the use of BCG to activate inflammatory and immune responses and she is currently working in the anti-inflammatory activities of specific cytokines and inhaled nitric oxide in the lung.
She has published more than one hundred scientific papers and reviews in top international journals. She is a member of the board of the Swiss Foundation for Tuberculosis Research since 2002.